A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Sponsor: Hoffmann-La Roche
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Hoffmann-La Roche
Listed as NCT02247479, this PHASE3 trial focuses on Geographic Atrophy and remains terminated or withdrawn. Sponsored by Hoffmann-La Roche, it has been updated 18 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
▶ Show 13 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Terminated PHASE3
-
May 2019 — Jul 2019 [monthly]
Terminated PHASE3
Status: Completed → Terminated
-
Nov 2018 — May 2019 [monthly]
Completed PHASE3
Status: Terminated → Completed
-
Oct 2018 — Nov 2018 [monthly]
Terminated PHASE3
Status: Completed → Terminated
-
Sep 2018 — Oct 2018 [monthly]
Completed PHASE3
-
Jul 2018 — Sep 2018 [monthly]
Completed PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Completed PHASE3
-
May 2018 — Jun 2018 [monthly]
Completed PHASE3
Status: Terminated → Completed
-
Apr 2018 — May 2018 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Dec 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .